Australia's most trusted
source of pharma news
Thursday, 10 July 2025
Posted 7 July 2025 AM
There are more pharmaceutical mega-blockbusters than ever before, despite the end of the Covid boom.
In 2024, 12 drugs reached mega-blockbuster status, defined as earning more than US$10 billion globally in a year, beating the record of 10 set the prior year, according to data technology company PharmCube.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.